IP Library Granted Patent US 10,220,058
Granted Patent B2
US 10,220,058 · App. 15/474,450 · Granted Mar 5, 2019

Spinal disc regenerative composition and method of manufacture and use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,220,058
App. No.
15/474,450
Granted
Mar 5, 2019
Kind
B2
Abstract

The present invention provides a novel way to replenish the disc using retooled disc compositions to repair degenerative discs. There is no better source of proteoglycans than the actual disc material ( 6 ) itself. To this end, there has been developed a technique to remove the nucleus pulposus and retool the morphology of the nucleus pulposus to create a powder material ( 10 ) that is dry and can be stored at room temperature for long periods of time. This powder ( 10 ) can then be reconstituted with a variety of fluids, the most suitable being normal saline or lactated ringers to form a flowable mixture ( 20 ).

Claims (36)

1. A method for regenerating damaged spinal disc, the method consisting of:

(a) obtaining from a human cadaver a normal intervertebral disc by sharp dissection;

(b) removing the nucleus pulposus from the annulus fibrosis of the normal intervertebral disc;

(c) hypothermically drying the nucleus pulposus to a moisture content of under 5 percent to form a dried material;

(d) micronizing the dried material at a low temperature by placing the dried material in a cryomill and pulverizing the dried material to form particles sized less than 400 microns to form a micronized material;

(e) placing the micronized material in a container for injection or in a syringe;

(f) aseptically hydrating the micronized material by adding a fluid to the container for injection or to the syringe, such that the hydrated micronized material has a high but flowable viscosity which is flowable as an injectable through a small bore cannula; and

(g) injecting the hydrated micronized material through a cannula into the damaged disc space, thereby regenerating the damaged disc.

2. The method of claim 1 wherein the treated disc regenerates or heals as evidenced by an increase in proteoglycans molecules.

3. A method for regenerating damaged spinal disc, the method consisting of:

(a) obtaining from a human cadaver a normal intervertebral disc by sharp dissection;

(b) removing the nucleus pulposus from the annulus fibrosis of the normal intervertebral disc.

(c) hypothermically drying the nucleus pulposus to a moisture content of under 5 percent to form a dried material;

(d) micronizing the dried material at a low temperature by placing the dried material in a cryomill and pulverizing the dried material to form particles sized less than 400 microns to form a micronized material;

(e) placing the micronized material in a container for injection or in a syringe;

(f) aseptically hydrating the micronized material by adding a fluid to the container for injection or to the syringe, such that the hydrated micronized material has a high but flowable viscosity which is flowable as an injectable through a small bore cannula;

(g) injecting the hydrated micronized material through a cannula into the damaged disc space, thereby regenerating the damaged disc; and

(h) sealing cracks in the damaged spinal disc with fibrin glue or other blood product to prevent leakage of the hydrated micronized material.

4. A method for regenerating damaged spinal disc, the method consisting of:

(a) obtaining from a human cadaver a normal intervertebral disc by sharp dissection;

(b) removing the nucleus pulposus from the annulus fibrosis of the normal intervertebral disc;

(c) hypothermically drying the nucleus pulposus to a moisture content of under 5 percent to form a dried material;

(d) micronizing the dried material at a low temperature by placing the dried material in a cryomill and pulverizing the dried material to form particles sized less than 400 microns to form a micronized material;

(e) placing the micronized material in a container for injection or in a syringe;

(f) aseptically hydrating the micronized material by adding a fluid to the container for injection or to the syringe, such that the hydrated micronized material has a high but flowable viscosity which is flowable as an injectable through a small bore cannula;

(g) injecting the hydrated micronized material through a cannula sized 2 mm or less into the damaged disc space, thereby regenerating the damaged disc; and

(h) sealing the hole in the damaged spinal disc with fibrin glue or another blood product.

5. A method for regenerating damaged spinal disc, the method consisting of:

(a) obtaining from a human cadaver a normal intervertebral disc by sharp dissection;

(b) removing the nucleus pulposus from the annulus fibrosis of the normal intervertebral disc;

(c) hypothermically drying the nucleus pulposus to a moisture content of under 5 percent to form a dried material;

(d) micronizing the dried material at a low temperature by placing the dried material in a cryomill and pulverizing the dried material to form particles sized less than 400 microns to form a micronized material;

(e) placing the micronized material in a container for injection or in a syringe;

(f) aseptically hydrating the micronized material by adding a fluid selected from the group consisting of normal saline, lactated ringers solution, blood, platelet rich plasma, or a combination thereof, and wherein the hydrated micronized material is a flowable mixture to the container for injection or to the syringe, such that the hydrated micronized material has a high but flowable viscosity which is flowable as an injectable through a small bore cannula;

(g) mixing the flowable mixture with one or more of stem cells that are derived from marrow, fat, blood or interspinous ligaments; micronized amnion; collagen Type 1 or glucose; and

(h) injecting the hydrated micronized material through a cannula into the damaged disc space, thereby regenerating the damaged disc.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2022
From: BANKUNITED, N.A.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 061333/0853 →
SECURITY INTEREST Recorded Aug 4, 2022
From: VIVEX BIOLOGICS GROUP, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 061084/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2020
From: TEMPLE, HARRY THOMAS
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 051966/0961 →
RELEASE OF SECURITY INTEREST Recorded Dec 12, 2019
From: HERITAGE BANK OF COMMERCE
To: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
Reel/Frame 051282/0653 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 11, 2019
From: VIVEX BIOLOGICS GROUP, INC.
To: BANKUNITED, N.A.
Reel/Frame 051260/0064 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOLOGICS, INC.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 050079/0225 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOMEDICAL, INC.
To: VIVEX BIOLOGICS, INC.
Reel/Frame 050079/0179 →
SECURITY INTEREST Recorded Mar 19, 2019
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 048629/0691 →
SECURITY INTEREST Recorded Apr 30, 2018
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 045671/0435 →